Pakhale Smita, Baron Justine, Armstrong Michael A, Garde Avanti, Reid Robert D, Alvarez Gonzalo, Aitken Debbie, Mullen Kerri-Anne, Wells George, Pipe Andrew
Can Respir J. 2015 Mar-Apr;22(2):91-6. doi: 10.1155/2015/871204. Epub 2015 Feb 3.
To assess the feasibility and potential effectiveness of a modified version of the Ottawa Model for Smoking Cessation in an outpatient respirology clinic.
Adult tobacco smokers attending the respirology clinic and willing to choose a quit date within one month of enrollment were randomly assigned to receive standard care or the intervention. Standard care participants received smoking cessation advice, a brochure and a prescription for smoking cessation medication if requested. Intervention participants received a $110 voucher to purchase smoking cessation pharmacotherapy and were registered to an automated calling system. Answers to automated calls determined which participants required nurse telephone counselling. Feasibility indicators included recruitment and retention rates, and intervention adherence. The effectiveness indicator was self-reported smoking status at 26 to 52 weeks.
Forty-nine (54.4%) of 90 eligible smokers were randomly assigned to the intervention (n=23) or control (n=26) group. Self-reported smoking status at 26 to 52 weeks was available for 32 (65.3%) participants. The quit rate for intervention participants was 18.2% compared with 7.7% for controls (OR2.36 [95% CI 0.39 to 14.15]).
It would be feasible to evaluate this intervention in a larger trial. Alternatives to face-to-face follow-up at the clinic are recommended.
评估渥太华戒烟模型的改良版在门诊呼吸科诊所的可行性和潜在效果。
到呼吸科诊所就诊且愿意在入组后一个月内选定戒烟日期的成年吸烟者被随机分配接受标准护理或干预措施。标准护理组参与者接受戒烟建议、一份手册,并根据需求开具戒烟药物处方。干预组参与者获得一张110美元的代金券用于购买戒烟药物疗法,并登记加入自动呼叫系统。对自动呼叫的回答确定哪些参与者需要护士电话咨询。可行性指标包括招募率、留存率和干预依从性。有效性指标是26至52周时自我报告的吸烟状况。
90名符合条件的吸烟者中有49名(54.4%)被随机分配到干预组(n = 23)或对照组(n = 26)。32名(65.3%)参与者提供了26至52周时自我报告的吸烟状况。干预组参与者的戒烟率为18.2%,而对照组为7.7%(比值比2.36 [95%置信区间0.39至14.15])。
在更大规模的试验中评估该干预措施是可行的。建议采用诊所面对面随访之外的其他方式。